106 related articles for article (PubMed ID: 25529769)
1. Tea consumption reduces the risk of de novo myelodysplastic syndromes.
Liu P; Zhang M; Jin J; Holman CD
Leuk Res; 2015 Feb; 39(2):164-9. PubMed ID: 25529769
[TBL] [Abstract][Full Text] [Related]
2. Case-control study of risk factors of myelodysplastic syndromes according to World Health Organization classification in a Chinese population.
Lv L; Lin G; Gao X; Wu C; Dai J; Yang Y; Zou H; Sun H; Gu M; Chen X; Fu H; Bao L
Am J Hematol; 2011 Feb; 86(2):163-9. PubMed ID: 21264898
[TBL] [Abstract][Full Text] [Related]
3. Dietary isoflavone intake is associated with a reduced risk of myelodysplastic syndromes.
Liu P; Holman CD; Jin J; Zhang M
Br J Nutr; 2015 Dec; 114(12):2110-5. PubMed ID: 26458988
[TBL] [Abstract][Full Text] [Related]
4. Green tea and the prevention of breast cancer: a case-control study in Southeast China.
Zhang M; Holman CD; Huang JP; Xie X
Carcinogenesis; 2007 May; 28(5):1074-8. PubMed ID: 17183063
[TBL] [Abstract][Full Text] [Related]
5. Alcohol consumption and risk of myelodysplastic syndromes: a case-control study.
Liu P; Holman CD; Jin J; Zhang M
Cancer Causes Control; 2016 Feb; 27(2):209-16. PubMed ID: 26590915
[TBL] [Abstract][Full Text] [Related]
6. Coffee and green tea consumption and subsequent risk of acute myeloid leukemia and myelodysplastic syndromes in Japan.
Ugai T; Matsuo K; Sawada N; Iwasaki M; Yamaji T; Shimazu T; Goto A; Inoue M; Kanda Y; Tsugane S;
Int J Cancer; 2018 Mar; 142(6):1130-1138. PubMed ID: 29076523
[TBL] [Abstract][Full Text] [Related]
7. [The application of a new prognostic score system for 435 cases of primary myelodysplastic syndrome diagnosed with WHO classification].
Wang XQ;
Zhonghua Nei Ke Za Zhi; 2009 Aug; 48(8):633-7. PubMed ID: 19954053
[TBL] [Abstract][Full Text] [Related]
8. Integrating WHO 2001-2008 criteria for the diagnosis of Myelodysplastic Syndrome (MDS): a case-case analysis of benzene exposure.
Irons RD; Gross SA; Le A; Wang XQ; Chen Y; Ryder J; Schnatter AR
Chem Biol Interact; 2010 Mar; 184(1-2):30-8. PubMed ID: 19941839
[TBL] [Abstract][Full Text] [Related]
9. Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome.
Dalamaga M; Karmaniolas K; Chamberland J; Nikolaidou A; Lekka A; Dionyssiou-Asteriou A; Mantzoros CS
Metabolism; 2013 Dec; 62(12):1830-9. PubMed ID: 24140093
[TBL] [Abstract][Full Text] [Related]
10. Risk factors of myelodysplastic syndromes: a case-control study.
Strom SS; Gu Y; Gruschkus SK; Pierce SA; Estey EH
Leukemia; 2005 Nov; 19(11):1912-8. PubMed ID: 16167059
[TBL] [Abstract][Full Text] [Related]
11. [WHO classification and cytogenetic analysis of 435 cases with myelodysplastic syndrome].
Wang XQ;
Zhonghua Nei Ke Za Zhi; 2008 Jun; 47(6):464-7. PubMed ID: 19040061
[TBL] [Abstract][Full Text] [Related]
12. The influence of cigarette smoking, alcohol, and green tea consumption on the risk of carcinoma of the cardia and distal stomach in Shanghai, China.
Ji BT; Chow WH; Yang G; McLaughlin JK; Gao RN; Zheng W; Shu XO; Jin F; Fraumeni JF; Gao YT
Cancer; 1996 Jun; 77(12):2449-57. PubMed ID: 8640692
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Green Tea Consumption on the Prevention of Hemorrhagic Stroke.
Lee SM; Choi NK; Yoon BW; Park JM; Han MK; Park BJ
Neuroepidemiology; 2015; 44(4):215-20. PubMed ID: 26021303
[TBL] [Abstract][Full Text] [Related]
14. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.
Malcovati L; Porta MG; Pascutto C; Invernizzi R; Boni M; Travaglino E; Passamonti F; Arcaini L; Maffioli M; Bernasconi P; Lazzarino M; Cazzola M
J Clin Oncol; 2005 Oct; 23(30):7594-603. PubMed ID: 16186598
[TBL] [Abstract][Full Text] [Related]
16. Tea consumption reduces ovarian cancer risk.
Lee AH; Su D; Pasalich M; Binns CW
Cancer Epidemiol; 2013 Feb; 37(1):54-9. PubMed ID: 23107758
[TBL] [Abstract][Full Text] [Related]
17. Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients.
Navarro I; Ruiz MA; Cabello A; Collado R; Ferrer R; Hueso J; Martinez J; Miguel A; Orero MT; Pérez P; Nolasco A; Carbonell F
Leuk Res; 2006 Aug; 30(8):971-7. PubMed ID: 16423393
[TBL] [Abstract][Full Text] [Related]
18. [A case-control study on green tea consumption and the risk of adult leukemia].
Zhang XD; Zhao XY; Zhang M; Liang Y; Xu XH; D'Arcy C; Holman J
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Mar; 29(3):290-3. PubMed ID: 18788532
[TBL] [Abstract][Full Text] [Related]
19. Tea consumption, incidence and long-term prognosis of a first acute myocardial infarction--the SHEEP study.
Pyshchyta G; Mukamal KJ; Ahnve S; Hallqvist J; Gémes K; Ahlbom A; Janszky I
Clin Nutr; 2012 Apr; 31(2):267-72. PubMed ID: 22075136
[TBL] [Abstract][Full Text] [Related]
20. Trends in incidence, initial treatment and survival of myelodysplastic syndromes: a population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010.
Dinmohamed AG; Visser O; van Norden Y; Huijgens PC; Sonneveld P; van de Loosdrecht AA; Jongen-Lavrencic M
Eur J Cancer; 2014 Mar; 50(5):1004-12. PubMed ID: 24388662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
